ClinConnect ClinConnect Logo
Search / Trial NCT06177132

Vestibular Infant Screening - Rehabilitation

Launched by UNIVERSITY HOSPITAL, GHENT · Dec 11, 2023

Trial Information

Current as of July 23, 2025

Not yet recruiting

Keywords

Therapy Vestibular Rehabilitation Therapy Vrt Gaze Stability Postural Control

ClinConnect Summary

This clinical trial, called the Vestibular Infant Screening - Rehabilitation, aims to explore how a specific rehabilitation program can help children aged 3 to 17 who have vestibular disorders, which can affect balance and coordination. The program, known as the VIS-REHAB protocol, includes exercises to improve stability and gaze control. Researchers want to see how effective this program is compared to a period when the children do not receive any therapy. They will look at improvements in balance, eye movements, motor skills, and overall quality of life.

To participate, children must have a diagnosed vestibular dysfunction, which means they have issues with their balance system, and they can have hearing loss or use cochlear implants. However, children with severe cognitive or physical disabilities that prevent them from following instructions or standing and walking independently will not be eligible. Families can expect that the trial will involve both active rehabilitation and a time with no therapy, allowing researchers to gather important information about the benefits of the VIS-REHAB program. This study is not yet recruiting participants, so interested families will need to wait for further announcements.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patients with identified vestibular dysfunction
  • With or without concomitant hearing loss and/or cochlear implant (CI)
  • Exclusion Criteria:
  • Children incapable to understand simple instructions (due to severe cognitive disorders, impaired language comprehension, etc.)
  • Severe disorders of other primary sensory input systems for balance function
  • Severe neuromotor disorders (incapable of independent standing and walking)
  • Severe muscle tone disorders (e.g. cerebral palsy)
  • Severe orthopaedic dysfunctions
  • Patients with vision problems that cannot be corrected for
  • Children with planned CI-surgery within 5 months before or during the study period

About University Hospital, Ghent

University Hospital Ghent is a leading academic medical institution renowned for its commitment to advancing healthcare through innovative research and clinical trials. Located in Ghent, Belgium, the hospital is affiliated with Ghent University, fostering a collaborative environment that integrates cutting-edge medical research with high-quality patient care. With a diverse range of specialized departments and a dedicated team of researchers and clinicians, University Hospital Ghent is at the forefront of developing new therapies and improving treatment protocols, aiming to enhance patient outcomes and contribute to the global medical community.

Locations

Gent, East Flanders, Belgium

Patients applied

0 patients applied

Trial Officials

Leen Maes, PhD

Principal Investigator

University Ghent

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported